---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-031292"
form_type: "8-K"
ticker: "IMNN"
cik: "0000749647"
company_name: "Imunon, Inc."
filed_at: "2026-06-30T20:30:34+00:00"
generated_at: "2026-06-30T20:32:19.494025+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Imunon CFO Jeffrey Church to retire; Josh Blacher appointed interim CFO effective July 1, 2026

## Summary
- Jeffrey Church retires as interim CFO effective July 1, 2026; will continue as consultant at $10,000/month retainer.
- Josh Blacher appointed interim CFO via Danforth Health, Inc. at $475/hour; serves as principal financial and accounting officer.
- Blacher, 54, has served as CFO for several life sciences companies including BullFrog AI, Inmed, Therapix, and Galmed.
- Church's departure is due to retirement and without any disagreements with management.

## SEC filing metadata
- accession: 0001493152-26-031292
- form_type: 8-K
- ticker: IMNN
- cik: 0000749647
- company_name: Imunon, Inc.
- filed_at: 2026-06-30T20:30:34+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/749647/000149315226031292/0001493152-26-031292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/749647/000149315226031292/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-031292
- JSON: https://secwatch.observer/filing/0001493152-26-031292.json
- Plain text: https://secwatch.observer/filing/0001493152-26-031292.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.